Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Topical botanical lotion increases hair density and improves quality of life in women with hair loss.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Hair stiffness is higher when it has more para-like cortical cells.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

ESR2 gene linked to female-pattern hair loss.

Topical melatonin is a safe treatment that may reduce hair loss in people with androgenetic alopecia.

Hair length and thickness are related, with thickness peaking at about a quarter of the hair's maximum length.

Trichotillometry is a reliable method to measure hair strength and assess hair loss treatments.

Most Spanish Caucasian women have a widow's peak, and their hormone levels suggest they process certain hormones faster.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

As people get older, they have less active hair growth, but women have thicker hair than men and respond better to hair loss treatments.

Women with certain types of hair loss may have low iron levels, and iron supplements could help.

Dermal macrophages might help regrow hair.

Early diagnosis is crucial for treating alopecia effectively.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

The Cross-section Trichometer is a promising tool for measuring hair characteristics without cutting the hair and may have various clinical uses.

Metabolic syndrome reduces effectiveness of hair loss treatment.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Exosomes show promise for future tissue regeneration.

Trichobiolight effectively treats hair loss with 82.5% success.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Finasteride increases hair count and improves hair growth with low risk of side effects.

The document explains the causes, types, diagnosis, and treatments of hair loss, and its psychological impact, especially on women.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.